New migraine pill under the tongue shows promise in early trial
NCT ID NCT06728553
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 2a trial tested whether a sublingual tablet called MTX101 can safely relieve migraine pain in adults. 78 participants took either the drug or a placebo during a migraine attack and tracked their symptoms. The study measured pain reduction and the need for rescue medication, along with any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MTX101 (a sublingual tablet)
What this could lead to
If it works, this could provide a new, fast-acting option for treating migraine headaches as they happen.
What could go wrong
This is an early pilot study with only 78 people, so results may not apply to everyone. The drug may not work better than a placebo, and side effects are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brainstorm Research
Miami, Florida, 33176, United States
-
Clinical Research Institute, LLC
Santa Monica, California, 90048, United States
-
DelRicht Research
New Orleans, Louisiana, 70115, United States
-
Kaizen Brain Center
La Jolla, California, 92037, United States
-
QUEST Research Institute
Farmington Hills, Michigan, 48334, United States
-
Synergy Clinical Research/Emerald Coast Center for Neurological Disorders
Pensacola, Florida, 32504, United States
-
Wasatch Clinical Research
Salt Lake City, Utah, 84107, United States